WebFeb 17, 2024 · Just click on the bell to see your five most-recent, unread notifications. Ok February 11, 2024—Patients with advanced renal cell carcinoma treated with nivolumab-ipilimumab versus sunitinib had somewhat different patterns of radiographic progression after 4 years of follow-up, according to an exploratory analysis of the CheckMate 214 trial. WebOct 14, 2024 · Rana R. McKay, MD. Dr Rana McKay discusses the efficacy and qualify-of-life data from the 5-year follow-up of the CheckMate 214 trial investigating nivolumab plus ipilimumab in frontline advanced renal cell …
Bristol Myers Squibb - Five-Year Data from CheckMate
WebApr 6, 2024 · Gillison ML, Blumenschein G Jr, Fayette J, et al. CheckMate 141: 1-year update and subgroup analysis of nivolumab as first-line therapy in patients with recurrent/metastatic head and neck cancer. Oncologist. 2024;23(9):1079-1082. doi:10.1634 ... extended 4-year follow-up of the phase III CheckMate 214 trial. WebNov 6, 2024 · Investigators presented updated efficacy and safety outcomes and conditional survival outcomes from CheckMate 214 (ClinicalTrials.gov Identifier: NCT02231749) with 5 years minimum follow-up... cooked with cannabis television series
First-Line Therapy of Advanced RCC With Nivolumab + Ipilimumab ...
WebPurpose To report updated analyses of the phase III CheckMate 214 trial with extended minimum follow-up assessing long-term outcomes with first-line nivolumab plus ipilimumab (NIVO+IPI) versus (vs) sunitinib (SUN) in patients with advanced renal cell carcinoma (aRCC).Methods Patients with aRCC with... WebSep 18, 2024 · Motzer R, Tannir N, McDermott D, et al. Conditional survival and 5-year follow-up in CheckMate 214: first-line nivolumab plus ipilimumab versus sunitinib in advanced renal cell carcinoma. Presented at: 2024 European Society for Medical Oncology Congress; September 16-21, 2024; virtual. Abstract 661P. WebJul 25, 2024 · During ASCO 2024, investigators presented 5-year updates for the combination of nivolumab plus ipilimumab in the first-line treatment of patients with metastatic NSCLC from part 1 of the... cooked wombat